NASDAQ: PSTV
Plus Therapeutics Inc Earnings Dates, Reports, Calls

Plus Therapeutics earnings were -$12.9M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest PSTV earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$2.9M, down 2.2% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, PSTV reported annual earnings of -$13.3M, with -34.3% growth.

PSTV earnings history

Current Revenue
$5.7M
Current Earnings
-$12.9M
Current Profit Margin
-225.1%

PSTV Return on Equity

Current Company
N/A
Current Industry
20%
Current Market
35.3%

PSTV Return on Assets

Current Company
-146.4%
Current Industry
1.4%
PSTV is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PSTV announces earnings.

PSTV Return on Capital Employed

Current Company
178.34%
Current Industry
14.3%
PSTV has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PSTV vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PSTV-$8.35M-$12.89MN/A-$2.27
MBRX-$30.02M-$30.15MN/A-$11.74
EYEN-$34.09M-$37.83MN/A-$0.71
CANF-$7.27M-$7.37MN/A-$3.00
COEP-$10.26M-$11.62MN/A-$0.28

Plus Therapeutics Earnings Reports & History FAQ

What were Plus Therapeutics's earnings last quarter?

On PSTV's earnings call on Invalid Date, Plus Therapeutics (NASDAQ: PSTV) reported Q3 2024 earnings per share (EPS) of -$0.37, up 63% year over year. Total PSTV earnings for the quarter were -$2.87 million. In the same quarter last year, Plus Therapeutics's earnings per share (EPS) was -$1.00.

If you're new to stock investing, here's how to buy Plus Therapeutics stock.

Is Plus Therapeutics profitable or losing money?

As of the last Plus Therapeutics earnings report, Plus Therapeutics is currently losing money. Plus Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$12.89 million, a 15.03% decrease year over year.

What was PSTV's earnings growth in the past year?

As of Plus Therapeutics's earnings date in Invalid Date, Plus Therapeutics's earnings has grown year over year. PSTV earnings in the past year totalled -$12.89 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.